AllianceBernstein’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
Other funds holding OSIR
HP
FIM
FPF
IA
MAM
AllianceBernstein's OSIR Position: Q1 2017 in Review
AllianceBernstein sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 40,692 shares — an estimated $200K sold.
AllianceBernstein first reported a position in OSIR in Q2 2013 and held it in 15 quarters. The position peaked at $792K in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.
- AllianceBernstein reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
- AllianceBernstein sold 40,692 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $200K.
- AllianceBernstein first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
- AllianceBernstein's Osiris Therapeutics, Inc. Common Stock position peaked at $792K in Q2 2015.
- 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.
Based on AllianceBernstein's 13F filing for Q1 2017, filed 11 May 2017.